Clofarabine clinical trials
Also written Clolar and Evoltra.
How each study uses Clofarabine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Clofarabine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 Dec 2004 · CLOLAR · NDA 021673 (FDA, Drugs@FDA)
- European Union
- 29 May 2006 · Evoltra · EMEA/H/C/000613 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
143 studies that test it; most in 2007 (19)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2002 | 5 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 7 |
| 2006 | 11 |
| 2007 | 19 |
| 2008 | 15 |
| 2009 | 14 |
| 2010 | 15 |
| 2011 | 9 |
| 2012 | 12 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 18 · Other 127
M.D. Anderson Cancer Center (27) · Genzyme, a Sanofi Company (15) · St. Jude Children's Research Hospital (10) · Memorial Sloan Kettering Cancer Center (8) · Masonic Cancer Center, University of Minnesota (4) · Nantes University Hospital (3) · Therapeutic Advances in Childhood Leukemia Consortium (3) · Massachusetts General Hospital (3)
Often tested with
Tested in the same studies.
Cytarabine (34) · Cyclophosphamide (22) · Busulfan (22) · Etoposide (16) · Melphalan (13) · Fludarabine (12) · Daunorubicin (7) · Dexamethasone (7)
Related medicines
As reviewed, each with the page that says it.
- One of Antimetabolites source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4
Studies that test Clofarabine.
- Dec 2026Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersPhase 2 · Memorial Sloan Kettering Cancer Center
- Dec 2026Vyxeos® With Clofarabine for Pediatric AMLPhase 1 · Princess Maxima Center for Pediatric Oncology
- May 2027Personalized NK Cell Therapy in CBTPhase 2 · M.D. Anderson Cancer Center
- Aug 2027Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaPhase 2 · M.D. Anderson Cancer Center
Studies
Open first, then newest update. How each study uses Clofarabine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 145
- Personalized NK Cell Therapy in CBTRecruitingPhase 2M.D. Anderson Cancer CenterNCT02727803Written as ClofarabineHow we know
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaRecruitingPhase 2M.D. Anderson Cancer CenterNCT03136146Written as ClofarabineHow we know
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07566377Written as ClofarabineHow we know
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT04644016Written as ClofarabineHow we know
- Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCTRecruitingPhase 2Nantes University HospitalNCT05917405Written as ClofarabineHow we know
- Vyxeos® With Clofarabine for Pediatric AMLRecruitingPhase 1Princess Maxima Center for Pediatric OncologyNCT07156435Written as ClofarabineHow we know
- Clofarabine Therapy in Locally Advanced or Metastatic Urothelial CarcinomaRecruitingPhase 1/2Ekaterina LaukhtinaNCT07034053Written as ClofarabineHow we know
- Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn DiseaseNot yet recruitingPhase 1/2Stanford UniversityNCT06986382Written as ClofarabineHow we know
- Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic LeukemiaActive, not recruitingPhase 2City of Hope Medical CenterNCT01885689Written as clofarabineHow we know
- Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic SyndromesCompletedPhase 1City of Hope Medical CenterNCT00641030Written as clofarabineHow we know
- Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment FailureCompletedPhase 2Nantes University HospitalNCT01188174Written as ClofarabineHow we know
- Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)CompletedPhase 2Nantes University HospitalNCT00863148Written as Clofarabine in combination with IV busulfan and ATGHow we know
- Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid LeukemiaTerminatedPhase 2Fred Hutchinson Cancer CenterNCT04994808Written as ClofarabineHow we know
- Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related DisordersActive, not recruitingPhase 2Dana-Farber Cancer InstituteNCT02425904Written as ClofarabineHow we know
- Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaActive, not recruitingPhase 2/3St. Jude Children's Research HospitalNCT03117751Written as ClofarabineHow we know
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive MutationsCompletedPhase 3National Cancer Institute (NCI)NCT02883049Written as ClofarabineHow we know
- Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid TumorsCompletedPhase 1National Cancer Institute (NCI)NCT02211755Written as Bortezomib plus ClofarabineHow we know
- Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic LeukemiaCompletedPhase 1University Hospital, LilleNCT01279096Written as ClofarabineHow we know
- Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched DonorsTerminatedPhase 2Memorial Sloan Kettering Cancer CenterNCT03615105Written as ClofarabineHow we know
- Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaCompletedPhase 1/2M.D. Anderson Cancer CenterNCT01701986Written as ClofarabineHow we know
See all 145 studies that test Clofarabine →
Given beside what is tested · 13 — Clofarabine is usual care or a partner of the new treatment
- Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft TransplantationRecruitingPhase 2Nantes University HospitalNCT06252870Written as ClofarabineHow we know
- Bisantrene Combination for Resistant AMLRecruitingPhase 2Sheba Medical CenterNCT04989335Written as ClofarabineHow we know
- Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AMLTerminatedPhase 1Malika KapadiaNCT05569512Written as ClofarabineHow we know
- Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)CompletedPhase 2M.D. Anderson Cancer CenterNCT02441803Written as ClofarabineHow we know
- Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and LymphomaCompletedPhase 2St. Jude Children's Research HospitalNCT01700946Written as clofarabineHow we know
- Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRICTerminatedPhase 2Nantes University HospitalNCT03263767Written as ClofarabineHow we know
- Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedPhase 3M.D. Anderson Cancer CenterNCT01471444Written as ClofarabineHow we know
- HSCT for High Risk Inherited Inborn ErrorsCompletedPhase 2Masonic Cancer Center, University of MinnesotaNCT00383448Written as ClofarabineHow we know
- Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or LymphomaTerminatedPhase 2St. Jude Children's Research HospitalNCT02518750Written as ClofarabineHow we know
- Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid LeukemiaCompletedPhase 1Nohla Therapeutics, Inc.NCT01031368Written as clofarabineHow we know
- Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)CompletedPhase 2M.D. Anderson Cancer CenterNCT00903760Written as ClofarabineHow we know
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic LeukemiaCompletedPhase 1National Cancer Institute (NCI)NCT01132573Written as clofarabineHow we know
- Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).CompletedPhase 2M.D. Anderson Cancer CenterNCT00088218Written as ClofarabineHow we know
Codes
What other systems call Clofarabine · ClinicalTrials.gg INT006811
- MeSH (NLM) D000077866ClofarabineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 762RDY0Y2HCLOFARABINEConfirmed FDA, NLM, Wikidata
- RxNorm 44151Confirmed FDA, Wikidata
- Wikidata Q5134875clofarabineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C26638ClofarabineOne source FDA
- DrugBank DB00631One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077866 | Clofarabine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 762RDY0Y2H | CLOFARABINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 44151 | — | Confirmed FDA, Wikidata |
| Wikidata | Q5134875 | clofarabine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C26638 | Clofarabine | One source FDA |
| DrugBank | DB00631 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.